We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks

By LabMedica International staff writers
Posted on 28 Aug 2020
A team of scientists have repurposed an artificial intelligence/machine learning-powered cough analysis mobile app for assessing respiratory health and associated COVID-19 risks.

The mobile app called kAs has been developed by Zensark Technologies (Hyderabad, Telangana, India), in collaboration with Salcit Technologies (Hyderabad, Telangana, India), to assess respiratory health of the patients by leveraging machine learning and disease specific cough signatures. More...
It brings the functionality of Spirometry using one's smartphone to carry out on demand assessments without the need to step out of the house. Patients can use their mobile phones to track the sound of their cough to assess and track their health.

The app has been developed based on the guidelines laid out by the WHO and asks 15 questions to the subject. The subject then cough into the mobile app which sends the cough sounds to the company’s AI platform Swaasa, where it undergoes an audiometric analysis and produces a composite COVID Risk Score, based on the answers to the questionnaire and the coughing sound. The app generates a rating on a scale of 1 to 10, with 10 being the highest risk level. The Risk Score of any individual can be tracked across multiple days or weeks. The subjects can be asked to submit cough samples as many times a day for as many days as necessary. Based on the samples and symptoms, the app tracks the risk level of each individual over time.

Anytime a subject is found to be breaching a threshold risk score, it is highlighted to public health officials on their dashboards. The dashboards are designed to show the population level statistics and can drill down to the detailed reports of an individual subject. The app also allows doctors, with an external microphone and wireless stethoscope to track various breathing and risk parameters.

Related Links:
Zensark Technologies
Salcit Technologies



Platinum Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
SARS-CoV-2 & Flu A/B RT-PCR Test
Mplex SARS-CoV-2+, Flu A, Flu B (C1) RT-PCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.